Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polypharmacy: the cure becomes the disease

C A Colley1, L M Lucas

  • 1Pharmacy Service, Veterans Affairs Medical Center, Portland, OR 97207.

Journal of General Internal Medicine
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A practice-based approach for converting from proton pump inhibitors to less costly therapy.

Effective clinical practice : ECP·2002
Same author

Comparative pathogenesis of tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC.

Journal of virology·2001
Same author

Monitoring theophylline therapy to prevent toxicity.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996
Same author

Sinusitis. A review for generalists.

The Western journal of medicine·1995
Same author

Verapamil-induced hepatotoxicity.

The Western journal of medicine·1994
Same author

The human skeleton: an overlooked but effective visual aid.

The Journal of rheumatology·1993

Polypharmacy, the use of unnecessary medications, is driven by patient, physician, and system factors. Strategies like patient education and simplifying drug regimens can mitigate risks and reduce healthcare costs.

Area of Science:

  • Gerontology
  • Pharmacology
  • Health Services Research

Background:

  • Polypharmacy, defined as a medical regimen including unnecessary medications, presents significant challenges in healthcare.
  • It is often exacerbated by patient-related factors (age, comorbidities, self-treatment), physician behaviors (overprescribing), and systemic issues (multiple providers, lack of coordination).

Purpose of the Study:

  • To identify the contributing factors to polypharmacy.
  • To outline the complications associated with polypharmacy.
  • To propose strategies for avoiding and managing polypharmacy.

Main Methods:

  • This review synthesizes information on the causes and consequences of polypharmacy.
  • It examines patient, physician, and system-level factors contributing to the problem.

Related Experiment Videos

  • It discusses interventions for simplification and avoidance of polypharmacy.

    • Main Results:

    • Polypharmacy leads to increased adverse drug reactions, noncompliance, hospitalizations, and associated costs.
    • Contributing factors include patient age, multiple medical problems, patient expectations, self-treatment, excessive prescribing, multiple providers, and lack of care coordination.

    Conclusions:

    • Polypharmacy can be effectively managed through patient education and shared decision-making regarding treatment goals.
    • Simplifying medication regimens by reducing duplication, decreasing dosing frequency, and regular review is crucial.
    • The primary goal is to achieve the least complex drug regimen feasible for the patient, balancing medical needs and cost.